These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 949552)

  • 1. Evidence for early recruitment of granulocyte precursors during high-dose methotrexate infusions in mice.
    Pinedo HM; Chabner BA; Zaharko DS; Bull JM
    Blood; 1976 Aug; 48(2):301-7. PubMed ID: 949552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.
    Pinedo HM; Zaharko DS; Bull J; Chabner BA
    Cancer Res; 1977 Feb; 37(2):445-50. PubMed ID: 832268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
    Laerum OD; Paukovits WR
    Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent (CFU-S) and granulocyte-committed (CFU-C) stem cells in intact and 89Sr marrow-ablated S1/S1d mice.
    Adler SS; Trobaugh FE
    Cell Tissue Kinet; 1978 Sep; 11(5):555-66. PubMed ID: 719697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice.
    Drutskaya MS; Ortiz M; Liepinsh DJ; Kuprash DV; Nedospasov SA; Keller JR
    Exp Hematol; 2005 Nov; 33(11):1348-56. PubMed ID: 16263419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative biochemical aspects of low and high doses of methotrexate in mice.
    Zaharko DS; Fung WP; Yang KH
    Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of myleran on murine hemopoiesis. I. Granulocytic cell line specificity of action on progenitor cells.
    Delmonte L
    Cell Tissue Kinet; 1978 Jul; 11(4):347-58. PubMed ID: 308393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of erythroid and granulocyte progenitors in the spleen as a function of stem cell dose.
    Hasthorpe S; Hodgson G
    Cell Tissue Kinet; 1977 Jan; 10(1):43-56. PubMed ID: 15727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo modulation of myelopoiesis by prostaglandin E2. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate.
    Gentile PS; Pelus LM
    Exp Hematol; 1987 Feb; 15(2):119-26. PubMed ID: 3469103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment.
    Patchen ML; MacVittie TJ
    Acta Haematol; 1983; 70(5):281-8. PubMed ID: 6414220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of a granulocytic inhibitor(s) on hematopoiesis in an in vivo culture system.
    MacVittie TJ; McCarthy KF
    Cell Tissue Kinet; 1975 Nov; 8(6):553-9. PubMed ID: 1201583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and magnitude of thermotolerance during chronic hyperthermia in murine granulocyte-macrophage progenitors: II.
    Xiong QB; O'Hara MD; Pollard MD; Leeper DB
    Int J Hyperthermia; 1996; 12(1):77-86. PubMed ID: 8676010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
    Gallicchio VS; Hughes NK
    Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for measuring suppression of hematopoiesis.
    Chervenick PA
    Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM; Zaharko DS; Bull JM; Chabner BA
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.
    Hudak S; Hunte B; Culpepper J; Menon S; Hannum C; Thompson-Snipes L; Rennick D
    Blood; 1995 May; 85(10):2747-55. PubMed ID: 7537980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin.
    Gentile P; Broxmeyer HE
    Blood; 1983 May; 61(5):982-93. PubMed ID: 6600950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.